4 weeks Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Recommendation of “Moderate Buy” from AnalystsMarketBeat
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the five research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst h…
Nasdaq 100 · Pharmaceuticals · Science
X